March 31, 2017 Chen Schor Dear Mr. Schor:Non-Disclosure Agreement • December 1st, 2017 • resTORbio, Inc. • Pharmaceutical preparations • Massachusetts
This letter agreement (the “Agreement”) confirms our agreement regarding your employment with resTORbio, Inc. (the “Company”) and shall be effective as of the date first written above.
BUSINESS SERVICES, PERSONNEL AND INFORMATION MANAGEMENT AGREEMENTBusiness Services, Personnel And • December 1st, 2017 • resTORbio, Inc. • Pharmaceutical preparations • Massachusetts
This Business Services, Personnel and Information Management Agreement (“Agreement”) is entered into to be effective as of August 1, 2016 (the “Effective Date”) by and between resTORbio, Inc., a Delaware Corporation (the “Operating Company”’), PureTech Management, Inc., a Delaware corporation (the “PTM”), PureTech Health LLC, a Delaware limited liability company (“PureTech”) and PureTech Health plc, a UK public limited company (“PTH plc”).
LICENSE AGREEMENTLicense Agreement • December 1st, 2017 • resTORbio, Inc. • Pharmaceutical preparations • Massachusetts
This License Agreement (“Agreement”), made as of March 23, 2017 (“Effective Date”), is by and between Novartis International Pharmaceutical Ltd., a for-profit corporation with its principal place of business at Lichtstrasse 35, CH-4056 Basel, Switzerland (“Novartis”) and resTORbio, Inc., a Delaware corporation located at 501 Boylston Street, Suite 6102, Boston, Massachusetts 02116 (“resTORbio”). Novartis and resTORbio are each referred to individually as a “Party” and together as the “Parties.”
